-K ϩ pump activation inhibits endothelium-dependent relaxation by activating the forward mode of Na ϩ /Ca 2ϩ exchanger in mouse aorta.
]i increase. KB-R7943 did not inhibit K ϩ -induced inhibition at up to 10 M but did at 30 M. In current-clamped MAECs, an increase in [K ϩ ]o from 6 to 12 mM depolarized the membrane potential, which was inhibited by ouabain, Ni 2ϩ , or KB-R7943. In aortic rings, the concentration of cGMP was significantly increased by acetylcholine and decreased on increasing [K ϩ ]o from 6 to 12 mM. This decrease in cGMP was significantly inhibited by pretreating with ouabain (100 M), Ni 2ϩ (300 M), or KB-R7943 (30 M). These results suggest that activation of the forward mode of NCX after Na ϩ -K ϩ pump activation inhibits Ca 2ϩ mobilization in endothelial cells, thereby modulating vasomotor tone. extracellular potassium; sodium-potassium pump; forward mode of sodium/calcium exchanger; endothelial cells; intracellular calcium THE NA ϩ -K ϩ PUMP and the Na ϩ /Ca 2ϩ exchanger (NCX) have an important role in modulating vascular contractility. Na ϩ -K ϩ pump activation relaxes vascular smooth muscle by hyperpolarizing the membrane potential (19, 24) , and Na ϩ -K ϩ pump inhibition contracts vascular smooth muscle through activating the reverse mode of NCX by Na ϩ accumulation in the myoplasm (9, 18) .
In endothelial cells, the roles of the Na ϩ -K ϩ pump and NCX are unclear and contradictory. It was reported that Na ϩ -K ϩ pump inhibition affects the synthesis or release of endothelium-derived relaxing factor(s) rather than its effector pathway (29) . On the other hand, we previously reported that Na ϩ -K ϩ pump activation inhibits Ca 2ϩ mobilization in endothelial cells and thereby endothelium-dependent relaxation (EDR) (26) . NCX is thought to contribute to endothelium-dependent control of vascular contractility (6, 25, 28) . These results support the involvement of the reverse mode of NCX in Ca 2ϩ mobilization in endothelial cells. However, little is known about the role of NCX operating in the forward mode.
The contribution of NCX to Ca 2ϩ mobilization is likely to vary, depending on the ability of a physiological stimulus to alter intracellular Na ϩ concentration ([Na ϩ ] i ) (16) . Because Na ϩ gradients across cell membrane are mainly achieved by the action of the Na ϩ -K ϩ pump, we hypothesized that Na ϩ -K ϩ pump activation would activate the forward mode of NCX. The present study was specifically designed to elucidate the roles of the Na ϩ -K ϩ pump and the forward mode of NCX in endothelium-dependent control of vascular contractility. We provide evidence for the concomitant activation of the Na ϩ -K ϩ pump and the forward mode of NCX during EDR.
METHODS

Contraction measurement on isolated aortic rings.
Five-to sixmonth-old mice of either gender were anesthetized by pentobarbital sodium (50 mg/kg body wt ip) and killed by cervical dislocation. Thoracic aorta was dissected out and cut into rings approximately 2.0 -3.0 mm long. A homemade myograph (14) was used to record the mechanical responses of these aortic ring segments. Each aortic ring was threaded with two strands of tungsten wire (120-m diameter): one anchored in the organ bath chamber (1 ml) and the other connected to a mechanotransducer (model FT-03, Grass). The chamber was perfused at a flow rate of 2.5 ml/min with oxygenated (95% O 2-5% CO2) Krebs-Ringer bicarbonate solution by using a peristaltic pump. The composition (in mM) of this solution was 118.3 NaCl, 4.7 KCl, 1.2 MgCl 2, 1.22 KH2PO4, 2.5 CaCl2, 25.0 NaHCO3, 11.1 glucose, pH 7.4. An optimal resting tension of 0.8 -1 g was applied.
Rings were precontracted with PGF 2␣ or norepinephrine (NE). EDR was induced by 3 M acetylcholine (ACh). When EDR had reached a maximum, extracellular K ϩ concentration ([K ϩ ]o) was increased from 6 to 12 mM to activate the Na ϩ -K ϩ pump. Mouse aorta endothelial cell culture, intracellular Ca 2ϩ concentration measurement, and current clamping. We isolated endothelial cells from mouse aorta (MAEC) using the primary explant technique, which is described in detail elsewhere (17, 27) . The cells were used up to passage 2 for functional studies. Membrane potential and intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) (using fura-2 AM) were measured as previously described (26) . The external solution (HEPES-buffered solution) contained (in mM) 150 NaCl, 6 KCl, 1.5 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose. The osmolarity of the solution, as measured with a vapor pressure osmometer (Fiske), was 320 Ϯ 5 mosM.
RT-PCR. Total RNA was extracted from MAECs that were prepared by using TRIzol reagent (Molecular Research Center; Cincin-nati, OH). First-strand cDNA was generated from total RNA using BcaBEST polymerase (Takara Shuzo). The specific oligonucleotide primers used for the PCR were 5Ј-CTTCTTCTTTCCCATCTG-CGTT-3Ј (sense) and 5Ј-GACTCTGACATTGCTAAGGTGC-3Ј (antisense). The size of the expected fragments was 783 bp. PCR was performed using Bca-optimized Taq polymerase (Takara Shuzo), and the conditionings used were as follows: initial denaturation for 1 min at 94°C, 35 amplification cycles (1 min at 94°C, 1.5 min at 55°C, and 1.5 min at 72°C for each cycle), a final extension of 10 min at 72°C, and rapid cooling to 4°C. PCR products were visualized on a 1% agarose gel using a 100-bp DNA ladder marker (New England BioLabs; Beverly, MA) as a standard.
Determination of mouse aorta cGMP levels. Mouse aortic rings, prepared as described above, were allowed to equilibrate in a chamber of a myograph, and one ring was mounted to record contractile response in the same chamber. The chamber was perfused at a flow rate of 2.5 ml/min with oxygenated (95% O2-5% CO2) Krebs-Ringer bicarbonate solution by using a peristaltic pump. Rings were precontracted with NE, and EDR was induced by 3 M ACh. When the mounted ring showed an expected response, the other rings were frozen in liquid nitrogen, and cGMP levels were measured using cGMP assay kits (EIA kit, R&D Systems) following the manufacture's protocol. Briefly, frozen tissue samples in liquid nitrogen were ground to a fine powder using a stainless steel mortar. After the liquid nitrogen had evaporated, the frozen tissue was homogenized in 300 l of 0.1 M HCl to stop the action of phosphodiesterase. Centrifugation was done at 10,000 rpm at 4°C, and the supernatant was then collected for quantitative immunoassay of cGMP levels. After incubation with p-nitrophenyl phosphate substrate, a microplate autoreader (E max ED 927, Molecular Devices Instruments) was used to measure the intensity of the bound yellow color at 405 nm. Total protein content in aorta homogenates was determined using a bicinchoninic acid protein assay kit (Pierce).
Chemicals. ACh, ATP, monensin, NE, N G -nitro-L-arginine methyl ester (L-NAME), ouabain, and PGF2␣ were purchased from Sigma; KB-R7943 from Tocris, 2Ј,4Ј-dichlorobenzamil (DCB) from Biomol, fura-2 AM from Molecular Probes, and Nystatin from ICN Biomedicals. Fura-2 AM and nystatin were applied from stock solutions in DMSO. KB-R7943, monensin, and DCB were applied from stock solutions in ethanol. Final concentrations of DMSO and ethanol were both Ͻ0.05%.
The mice were treated in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, Revised 1996), and the experimental and animal care protocol was approved by the Animal Care and Use Committee of Ewha Women's University. All experiments were performed at 37°C. Pooled data are presented as means Ϯ SE, and significant differences were detected using the Student's t-test (P Ͻ 0.05).
RESULTS
Presence of NCX in MAECs.
The Na ϩ ionophore monensin relaxed precontracted endothelium-intact aortic rings in a concentration-dependent manner ( Fig. 1, A, B , and D). Monensin induced 25.2 Ϯ 4.3% relaxation at 0.1 M, and this relaxation was completely inhibited by KB-R7943 (Fig. 1A) . In contrast, endothelium-denuded aortic rings (Fig. 1C) or endotheliumintact aortic rings pretreated with the nitric oxide (NO) synthase inhibitor L-NAME (30 M) (data not shown) showed no relaxation on administration of monensin (0.1 M), indicating that the KB-R7943-sensitive, monensin-induced relaxation was EDR. On the other hand, monensin relaxed not only precontracted endothelium-intact aortic rings but also endothelium-denuded aorta at high concentrations (Ͼ1 M). Monensin (1 M) induced 56.5 Ϯ 4.8 and 10.3 Ϯ 3.1% relaxation in endothelium-intact and -denuded aortic rings, respectively ( Fig. 1, B-D) , and this relaxation was significantly greater in endothelium-intact aortic rings (Fig. 1D ). Monensin-induced relaxation of endothelium-denuded aortic rings was not inhibited by KB-R7943 (data not shown). We then examined the effects of monensin-induced Na ϩ loading and extracellular Na ϩ depletion (Na ϩ replaced by Li
] i in MAEC (Fig. 1, E and F creased by extracellular Na ϩ depletion, and this Na ϩ depletion-induced [Ca 2ϩ ] i increase was inhibited by KB-R7943. Inasmuch as the above results suggested the presence of NCX, we next performed RT-PCR using mRNA of freshly isolated MAECs to examine whether the cells contain a molecular candidate for NCX. As a complete sequence for mouse NCX has been published, we performed RT-PCR using primers based on this NCX sequence. Figure 1H shows that an abundant RT-PCR product was found at the expected molecular size using a PCR primer set, indicating that NCX1 mRNA is expressed in MAECs.
[ (Fig. 2A) . This K ϩ -induced inhibition of EDR was almost completely abolished by monensin (0.1 M) pretreatment for 30 min (Fig. 2B) . In addition, 1 M monensin completely inhibited K ϩ -induced inhibition of EDR (Fig. 2, C and D) . We then examined the effect of monensin-induced Na ϩ loading on K (Fig. 3A) . In contrast, 300 M Ni 2ϩ did not relax endothelium-intact aortic rings pretreated with L-NAME (30 M) (Fig. 3B) or endothelium-denuded aortic rings (data not shown). These results suggest that the NCX inhibitor Ni 2ϩ inhibits K ϩ -induced inhibition of EDR. Pretreatment with Ni 2ϩ for 5 min also inhibited K ϩ -induced inhibition of EDR (Fig. 3, C-E (Fig.  4) . In control rings, EDR was almost completely inhibited by extracellular K ϩ (Fig. 4, A and D) . EDR of 81.0 Ϯ 1.6% was reduced to 3.1 Ϯ 1.9% by increasing [K ϩ ] o from 6 to 12 mM (n ϭ 6). The aortic rings were then pretreated with DCB for 10 min. DCB pretreatment inhibited K ϩ -induced inhibition of EDR in a concentration-dependent manner. Pretreatment with 10 M DCB partially inhibited K ϩ -induced inhibition of EDR. EDR of 88.8 Ϯ 1.0% was reduced to 50.1 Ϯ 5.1% by increasing [K ϩ ] o from 6 to 12 mM (Fig. 4, B and D) . Furthermore, pretreatment with 30 M DCB almost completely abolished K ϩ -induced inhibition of EDR (Fig. 4, C and D) . EDR of 89.0 Ϯ 1.7% was slightly reduced to 81.0 Ϯ 1.2% by increasing [K ϩ ] o from 6 to 12 mM. In addition, pretreatment with Ni 2ϩ or DCB potentiated EDR (Figs. 3E and 4D) . EDRs of 90.9 Ϯ 4.1% and 81.0 Ϯ 1.6% were significantly increased to 94.6 Ϯ 5.1% and 88.8 Ϯ 1.0% by pretreating with Ni 2ϩ and DCB, respectively. The potentiating effect of DCB on EDR was more evident, when a low concentration of ACh (0.3 M) was used to induce EDR (Fig. 4, E-G) . The EDR of 34.6 Ϯ 4.9% was significantly increased to 68.3 Ϯ 4.1% by pretreating with DCB (n ϭ 6).
KB-R7943 (the reverse mode inhibitor) did not inhibit K ϩ -induced inhibition of EDR or [Ca 2ϩ ] i increase at up to 10 M (Fig. 5, B and E) . When the aortic rings were pretreated with 10 M KB-R7943, K ϩ -induced inhibition of EDR was still evoked (Fig. 5B) . In contrast, KB-R7943 completely abolished K ϩ -induced inhibition of EDR at 30 M (Fig. 5C ). In addition, KB-R7943 inhibited K ϩ -induced inhibition of [Ca 2ϩ ] i increase at 30 M (Fig. 5, E and F) (Fig. 5, A-D) .
Concomitant activation of Na ϩ -K ϩ pump and the forward mode of NCX. The above data suggests that the Na ϩ -K ϩ pump and the forward mode of NCX are simultaneously activated by increasing [K ϩ ] o . Because activation of the Na ϩ -K ϩ pump and the forward mode of NCX might affect the membrane potential, we examined the effect of ouabain and NCX blockers on the membrane potential. An increase in [K ϩ ] o from 6 to 12 mM depolarized the resting membrane potential from Ϫ29.8 Ϯ 4.8 to Ϫ3.1 Ϯ 3.8 mV in current-clamped MAECs (n ϭ 14) (Figs. 6C and 7B), and this effect of extracellular K ϩ was inhibited by ouabain (100 M) or Ni 2ϩ (300 M). Depolarized membrane potential was significantly hyperpolarized by ouabain or Ni 2ϩ from Ϫ2.1 Ϯ 5.5 to Ϫ9.6 Ϯ 5.1 mV (n ϭ 12) (Fig. 6, C and  D) and from Ϫ3.9 Ϯ 4.1 to Ϫ15.4 Ϯ 3.2 mV (n ϭ 11) (Fig. 7 , B and C), respectively. In addition, KB-R7943 also hyperpolarized this depolarized potential (Fig. 7D) . In contrast, when [K ϩ ] o was maintained at 6 mM, the membrane potential was significantly depolarized by ouabain (100 M) from Ϫ27.8 Ϯ 5.8 to Ϫ20.6 Ϯ 6.0 mV (n ϭ 9) (Fig. 6, A and B) and not changed by Ni 2ϩ (300 M, n ϭ 8) or KB-R7943 (Fig. 7A ). These data suggest that the Na ϩ -K ϩ pump and the forward mode of NCX are simultaneously activated by extracellular K ϩ .
Effect of extracellular K
ϩ on cGMP levels. When [Ca 2ϩ ] i in endothelial cells is increased, endothelium-derived NO is released from endothelial cells. This released NO increases cGMP levels in vascular smooth muscle and thereby relaxes vascular smooth muscle. Thus we examined the effect of extracellular K ϩ on cGMP levels in aortic rings (Fig. 8) . The cGMP level in aortic rings exposed to NE (1 M) was 1.37 Ϯ 0.37 pmol/mg protein. When aortic rings were exposed to NE and then to ACh (3 M), this level was significantly increased to 107.42 Ϯ 11.11 pmol/mg protein. After K ϩ -induced inhibition of EDR was evoked, it fell significantly to 7.25 Ϯ 1.36 pmol/mg protein (K ϩ -induced inhibition of cGMP production). K ϩ -induced inhibition of cGMP production was significantly inhibited by pretreating with ouabain (100 M), Ni 2ϩ (300 M), or KB-R7943 (30 M).
DISCUSSION
This study provides new evidence concerning the roles of the Na ϩ -K ϩ pump and the forward mode of NCX in endothelium-dependent vasorelaxation. In endothelial and vascular smooth muscle cells, an increase in [Ca 2ϩ ] i by various stimuli stimulates Ca 2ϩ -activated K ϩ channels (5, 22) . This activation in turn induces an efflux of intracellular K ϩ and may increase K ϩ concentration transiently in the extracellular space close to the cell membrane. It was reported that endothelial cell stimulation by ACh raises the K ϩ concentration in the myoendothelial space by 5.9 Ϯ 1.0 mM (7 ] i increase. This subsequent activation of the forward mode of NCX after Na ϩ -K ϩ pump activation is consistent with a previous finding that the NCX current reverses from an outward to an inward direction during Na ϩ -K ϩ pump activation (3, 10) . These findings revealed a dynamic interaction between the two Na ϩ transport mechanisms, the Na ϩ -K We found that KB-R7943 at low concentrations (up to 10 M) did not change ATP-induced Ca 2ϩ transients in MAECs, which is consistent with the finding that KB-R7943 at 1 M did not inhibit EDR (25) . In addition, we found that the subtype of NCX in MAECs is NCX1. These data suggest that the reverse mode of NCX does not contribute to EDR under physiological conditions, since KB-R7943 inhibits the reverse mode of NCX1 at low concentration (IC 50 ϭ 1.2-2.4 M) (13) . The reverse mode of NCX may contribute EDR in pathophysiological conditions such as Na ϩ -loaded conditions or hyponatremia (Ͻ100 mM) (25) . On the other hand, KB-R7943 inhibited EDR at a high concentration (Ͼ10 M). This inhibition can be explained by the finding that KB-R7943 (Ͼ10 M) inhibited ATP-induced Ca 2ϩ transients (Fig. 5D ). It was reported that KB-R7943, at a high concentration (30 M), affected other ion transporters such as Na ϩ /H ϩ exchanger, Ca 2ϩ channels, Ca 2ϩ pumps, Na ϩ -K ϩ pump, and Na ϩ channels (13, 23) . Thus we suggest that KB-R7943 inhibits EDR by affecting these ion transporters on endothelial or smooth muscle cells at a high concentration.
Physiological implications: role of NCX in EDR. In this study, we found that the magnitude of EDR is significantly increased by the NCX (forward and reverse mode) inhibitors Ni 2ϩ or DCB. This finding indicates that the forward mode of NCX reduces EDR in physiological conditions. In physiological conditions and in the absence of Na ϩ loading, NCX seems to contribute to Ca 2ϩ extrusion during cell activation to prevent Ca 2ϩ overload (11) . Because K ϩ is released to the extracellular space through Ca 2ϩ -activated K ϩ channels during endothelial cell activation, we speculate a dynamic interaction between Ca 2ϩ -activated K ϩ channels, the Na ϩ -K ϩ pump, and NCX. During cell activation, the increased intracellular Ca 2ϩ stimulates Ca 2ϩ -activated K ϩ channel, which releases K ϩ to the extracellular space. This released K ϩ then activates Na ] i and sensitively control NO release. This control in NO release may be important, because NO is converted to toxic species such as peroxynitrite on reacting with oxygen radicals (4, 12, 15, 20, 21) . This mechanism may enable endothelial cells to release an appropriate amount of NO by regulating increases in [Ca 2ϩ ] i . On the other hand, as shown in this study, the reverse mode of NCX increases [Ca 2ϩ ] i and evokes EDR in Na ϩ -loaded conditions (6, 25, 28) . In pathophysiological situations such as under oxidative stress, excessive Na ϩ entry via redox-activated cation channels has been observed (2, 8) . The resulting profound Na ϩ loading is expected to activate the reverse mode of NCX. Therefore, we suggest Na ϩ -Ca 2ϩ exchange is a physiological and pathophysiological link between Na ϩ homeostasis and Ca 2ϩ -associated cell signaling. In conclusion, we show here that activation of the forward mode of NCX following Na ϩ -K ϩ pump activation decreases [Ca 2ϩ ] i within endothelial cells and thus inhibits EDR. We suggest a dynamic interaction between Ca 2ϩ -activated K ϩ channels, the Na ϩ -K ϩ pump, and NCX, which enables endothelial cells to sensitively control Ca 2ϩ influx, and therefore [Ca 2ϩ ] i , and may be a mechanism by which endothelial cells sensitively modulate vasomotor activity.
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